Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SEVSX | 43.29 | 0.54 | +1.26% |
| NAA SMid Cap Value C | |||
| TOLZX | 16.67 | 0.15 | +0.91% |
| DWS RREEF Global Infrastructure R6 | |||
| GREUX | 12.00 | 0.10 | +0.84% |
| Goldman Sachs Real Estate Securities R6 | |||
| HFYYX | 13.16 | 0.08 | +0.57% |
| Hartford Schroders Intl Multi-Cp Val Y | |||
| RRCOX | 64.65 | 0.35 | +0.54% |
| T. Rowe Price U.S. Equity Research R | |||
A.I.dvisor indicates that over the last year, IVEVF has been loosely correlated with TRDA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if IVEVF jumps, then TRDA could also see price increases.
| Ticker / NAME | Correlation To IVEVF | 1D Price Change % | ||
|---|---|---|---|---|
| IVEVF | 100% | N/A | ||
| TRDA - IVEVF | 47% Loosely correlated | +3.94% | ||
| MBCOF - IVEVF | 32% Poorly correlated | -2.07% | ||
| EPRX - IVEVF | 28% Poorly correlated | -0.35% | ||
| ATHE - IVEVF | 25% Poorly correlated | -2.66% | ||
| IDRSF - IVEVF | 20% Poorly correlated | N/A | ||
More | ||||